Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Bhosle · SciRah

Researcher profile · Semantic Scholar

J. Bhosle

Share profile

J. Bhosle — researcher profile on SciRah

h-index: 18
Works: 115
Citations: 924

Most-cited papers

Systemic treatment of brain metastases in non-small cell lung cancer.
S. Page, C. Milner-Watts, M. Perna, U. Janžič +9 more
2020European Journal of Cancer104 citations
Semantic Scholar
Clinical Activity, Tolerability, and Long-term Follow-up of Durvalumab in Patients With Advanced NSCLC.
S. Antonia, A. Balmanoukian, J. Brahmer, S. Ou +27 more
2019Journal of Thoracic Oncology90 citations Open access
Semantic Scholar
Efficient Genotyping of KRAS Mutant Non-Small Cell Lung Cancer Using a Multiplexed Droplet Digital PCR Approach
A. Pender, I. Garcia-Murillas, S. Rana, R. Cutts +9 more
2015PLoS ONE62 citations Open access
Semantic Scholar
A randomised study comparing the effectiveness of acupuncture or morphine versus the combination for the relief of dyspnoea in patients with advanced non-small cell lung cancer and mesothelioma.
A. Minchom, R. Punwani, Jacqueline Filshie, J. Bhosle +5 more
2016European Journal of Cancer45 citations
Semantic Scholar
Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP): A randomised, double-blind, placebo-controlled phase II trial.
P. Woll, P. Gaunt, Sarah J. Danson, Nicola Steele +7 more
2022Lung Cancer39 citations Open access
Semantic Scholar
Up-front cell-free DNA next generation sequencing improves target identification in UK first line advanced non-small cell lung cancer (NSCLC) patients.
W. Cui, C. Milner-Watts, H. O'Sullivan, H. Lyons +10 more
2022European Journal of Cancer37 citations Open access
Semantic Scholar
Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancer
V. Angelis, Zayd Tippu, K. Joshi, S. Reis +16 more
2020European Journal of Cancer33 citations Open access
Semantic Scholar
Development of molecularly targeted agents and immunotherapies in small cell lung cancer.
A. Sharp, J. Bhosle, F. Abdelraouf, S. Popat +2 more
2016European Journal of Cancer33 citations
Semantic Scholar
Mechanism and non-mechanism based imaging biomarkers for assessing biological response to treatment in non-small cell lung cancer.
Alex Weller, M. O'Brien, Merina Ahmed, Sanjay Popat +6 more
2016European Journal of Cancer30 citations
Semantic Scholar
Rationale and Design of the Phase III KEYLYNK-012 Study of Pembrolizumab and Concurrent Chemoradiotherapy Followed by Pembrolizumab With or Without Olaparib for Stage III Non-Small-Cell Lung Cancer
S. Jabbour, B. Cho, E. Bria, T. Kato +9 more
2022Clinical Lung Cancer29 citations
Semantic Scholar
AKT inhibition synergistically enhances growth-inhibitory effects of gefitinib and increases apoptosis in non-small cell lung cancer cell lines.
M. Puglisi, P. Thavasu, A. Stewart, J. de Bono +4 more
2014Lung Cancer29 citations
Semantic Scholar
Molecular Adequacy of Image‐Guided Rebiopsies for Molecular Retesting in Advanced Non–Small Cell Lung Cancer: A Single‐Center Experience
N. Tokaca, S. Barth, M. O'Brien, J. Bhosle +4 more
2018Journal of Thoracic Oncology27 citations Open access
Semantic Scholar
MA09.05 Nivolumab Alone or with Ipilimumab in Recurrent Small Cell Lung Cancer (SCLC): 2-Year Survival and Updated Analyses from the Checkmate 032 Trial
M. Hellmann, S. Antonia, S. Ponce, P. Ott +26 more
201724 citations Open access
Semantic Scholar
HER3 expression and MEK activation in non-small-cell lung carcinoma
T. Manickavasagar, W. Yuan, S. Carreira, B. Gurel +12 more
2021Lung Cancer Management20 citations Open access
Semantic Scholar
Contemporary management of voice and swallowing disorders in patients with advanced lung cancer
Gráinne C. Brady, P. Carding, J. Bhosle, J. Roe
2015Current Opinion in Otolaryngology & Head and Neck Surgery16 citations
Semantic Scholar
A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients
Rajiv Kumar, S. Lu, A. Minchom, A. Sharp +6 more
2016Cancer Chemotherapy and Pharmacology15 citations
Semantic Scholar
Epidermal Growth Factor Mutation as a Diagnostic and Therapeutic Target in Metastatic Poorly Differentiated Thyroid Carcinoma: A Case Report and Review of the Literature
H. Lote, J. Bhosle, K. Thway, K. Newbold +1 more
2014Case Reports in Oncology15 citations Open access
Semantic Scholar
A study of PD-L1 expression in KRAS mutant non-small cell lung cancer cell lines exposed to relevant targeted treatments
A. Minchom, P. Thavasu, Zai Ahmad, A. Stewart +7 more
2017PLoS ONE14 citations Open access
Semantic Scholar
Immune Checkpoint Inhibitor and Radiotherapy-Related Pneumonitis: An Informatics Approach to Determine Real-World Incidence, Severity, Management, and Resource Implications
S. Hindocha, D. Campbell, Merina Ahmed, K. Giorgakoudi +14 more
2021Frontiers in Medicine9 citations Open access
Semantic Scholar
A randomised assessment of the use of a quality of life questionnaire with or without intervention in patients attending a thoracic cancer clinic
K. Nimako, B. Ayite, K. Priest, J. Severn +5 more
2017European Journal of Cancer Care8 citations Open access
Semantic Scholar
Focused molecular analysis of small cell lung cancer: feasibility in routine clinical practice
F. Abdelraouf, A. Sharp, Manisha Maurya, D. Mair +9 more
2015BMC Research Notes8 citations Open access
Semantic Scholar
Characterisation of the Phosphatidylinositol 3-Kinase Pathway in Non-Small Cell Lung Cancer Cells Isolated from Pleural Effusions
M. Puglisi, A. Stewart, P. Thavasu, M. Frow +10 more
2016Oncology6 citations
Semantic Scholar
Safety monitoring of two and four-weekly adjuvant durvalumab for patients with stage III NSCLC: implications for the COVID-19 pandemic and beyond
K. Joshi, A. Muhith, M. Obeid, C. Milner-Watts +7 more
2021Lung Cancer5 citations Open access
Semantic Scholar
1256TiP Phase III study of pembrolizumab (Pembro) with concurrent chemoradiation therapy (CCRT) followed by pembro with or without olaparib (Ola) vs CCRT followed by durvalumab (Durva) in unresectable, locally advanced, stage III non-small cell lung cancer (NSCLC): KEYLYNK-012
S. Jabbour, B. Cho, E. Bria, T. Kato +9 more
20205 citations Open access
Semantic Scholar
Real-world outcomes in thoracic cancer patients with severe Acute respiratory syndrome Coronavirus 2 (COVID-19): Single UK institution experience
W. Cui, Nadia Yousaf, J. Bhosle, A. Minchom +7 more
2020Cancer Treatment and Research Communications5 citations Open access
Semantic Scholar
A phase I study to assess afatinib in combination with carboplatin or with carboplatin plus paclitaxel in patients with advanced solid tumors
M. O'Brien, D. Sarker, J. Bhosle, K. Thillai +7 more
2018Cancer Chemotherapy and Pharmacology5 citations Open access
Semantic Scholar
Clinical outcomes and prognostic factors of patients with advanced mesothelioma treated in a phase I clinical trials unit.
D. Papadatos-Pastos, D. Roda, M. D. De Miguel Luken, A. Petruckevitch +12 more
2017European Journal of Cancer5 citations
Semantic Scholar
The Predictive Value of the G8 Questionnaire in Older Patients with Lung Cancer or Mesothelioma before Systemic Treatment.
X. Wu, R. Kumar, C. Milner-Watts, D. Walder +4 more
2022Clinics in oncology4 citations
Semantic Scholar
Phase I clinical trials in patients with advanced non-small cell lung cancer treated within a Drug Development Unit: What have we learnt?
M. Capelán, D. Roda, E. Geuna, K. Rihawi +8 more
2017Lung Cancer4 citations Open access
Semantic Scholar
Molecular characterization of PDL1 status of circulating tumor cells (CTCs) isolated with a novel label-free inertial microfluidic system from patients (pts) with advanced cancers
J. Fraser-Fish, Zai Ahmad, Rakesh Kumar, Berni Ebbs +10 more
20164 citations Open access
Semantic Scholar
Phase 3 study of pembrolizumab with concurrent chemoradiation therapy followed by pembrolizumab with or without olaparib versus concurrent chemoradiation therapy followed by durvalumab in unresectable, locally advanced, stage III non-small cell lung cancer: KEYLYNK-012.
S. Jabbour, B. Cho, E. Bria, T. Kato +9 more
20213 citations
Semantic Scholar
149P Real-world outcomes with first-line afatinib in EGFR mutant NSCLC adenocarcinoma: A single centre experience exploring effects of dose-reduction
N. Tokaca, M. O'Brien, J. Bhosle, Nadia Yousaf +3 more
20183 citations Open access
Semantic Scholar
180P Incidence of brain metastases (BM) in newly diagnosed stage IV NSCLC during COVID-19
W. Cui, C. Milner-Watts, S. Saith, J. Bhosle +7 more
2021Journal of Thoracic Oncology2 citations Open access
Semantic Scholar
A prospective observational study of on-treatment plasma homocysteine levels as a biomarker of toxicity, depression and vitamin supplementation lead-in time pre pemetrexed, in patients with non-small cell lung cancer and malignant mesothelioma
A. Minchom, D. Mak, R. Gunapala, D. Walder +6 more
2019PLoS ONE2 citations Open access
Semantic Scholar
Abstract 2243: Characterization of PD-L1 expression on circulating tumor cells (CTCs) isolated with a label-free inertial microfluidic system from advanced non-small cell lung cancer patients (NSCLC pts)
Zai Ahmad, J. Fraser-Fish, Rajiv Kumar, Bernadette Ebbs +9 more
20162 citations
Semantic Scholar
Stereotactic radiosurgery (SRS) for non-small cell lung cancer (NSCLC) in the oncogene-addicted era: A real-world UK tertiary center experience.
D. Mcmahon, J. de Boisanger, Alexius John, M. Brewer +16 more
2024Journal of Clinical Oncology1 citations
Semantic Scholar
MA12.09 Frequency and Detectability of Uncommon EGFR Mutations in NSCLC
H. O'Sullivan, S. Macmahon, W. Cui, C. Milner-Watts +7 more
2022Journal of Thoracic Oncology1 citations Open access
Semantic Scholar
EP08.02-124 Lorlatinib Treatment Related Adverse Events: Single Centre Real-World Experience in ALK and ROS1-driven NSCLC
P. Begum, H. O'Sullvan, P. d'Arienzo, N. Cunningham +8 more
2022Journal of Thoracic Oncology1 citations Open access
Semantic Scholar
KEYLYNK-012: A Phase 3 Study of Pembrolizumab With Concurrent Chemoradiation Therapy (CCRT) Followed by Pembrolizumab With or Without Olaparib vs. CCRT Followed by Durvalumab in Unresectable, Locally Advanced, Stage III Non‒Small-Cell Lung Cancer.
S. Jabbour, B. Cho, E. Bria, T. Kato +9 more
2021International Journal of Radiation Oncology, Biology, Physics1 citations
Semantic Scholar
1352P Circulating tumour (ct) DNA next generation sequencing (NGS) in advanced non-small cell lung cancer (mNSCLC): A UK single institution experience
W. Cui, C. Milner-Watts, I. Faull, R. Nagy +6 more
20201 citations Open access
Semantic Scholar
1748P Real-world outcomes in thoracic cancer patients (pts) with severe acute respiratory syndrome coronavirus 2 (COVID-19): Single UK institution experience
W. Cui, Nadia Yousaf, J. Bhosle, A. Minchom +6 more
2020Annals of Oncology1 citations Open access
Semantic Scholar
1241P Safety monitoring of adjuvant 2 weekly durvalumab for patients with stage III NSCLC: Implications for a 4 weekly regimen during the COVID-19 pandemic and beyond
K. Joshi, A. Muhith, C. Milner-Watts, M. Obeid +4 more
2020Annals of Oncology1 citations Open access
Semantic Scholar
Phase I dose escalation of pembrolizumab given concurrently with palliative thoracic radiotherapy (RT) for NSCLC.
Rajiv Kumar, D. Walder, A. Pejanaute, R. Gunapala +11 more
2018Annals of Oncology1 citations Open access
Semantic Scholar
P3.05-006 Anxiolytic Effect of Acupuncture in a Phase II Study of Acupuncture and Morphine for Dyspnea in Lung Cancer and Mesothelioma: Topic: Symptoms, Therapeutic Interventions
A. Minchom, R. Punwani, J. Filshie, J. Bhosle +5 more
20171 citations Open access
Semantic Scholar
Simultaneous EGFR mutation detection and copy number assessment in circulating tumour DNA (ctDNA) to inform molecular methods of therapy resistance and plasma ctDNA content in lung adenocarcinoma.
A. Pender, S. Rana, I. Garcia-Murillas, R. Cutts +6 more
20161 citations
Semantic Scholar
3 EGFR mutant circulating tumour DNA detection in advanced lung adenocarcinoma: optimising the application of a ctDNA diagnostic to real world clinical practice
A. Pender, S. Rana, E. Delgado, P. Proszek +8 more
20161 citations
Semantic Scholar
A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice
M. Linch, S. Gennatas, Stanislav Kazikin, J. Iqbal +8 more
2014BMC Cancer1 citations Open access
Semantic Scholar
An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12 and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicity
A. Minchom, K. Saksornchai, J. Bhosle, R. Gunapala +8 more
2014BMJ Open Respiratory Research1 citations Open access
Semantic Scholar
Development in the diagnostic lung cancer pathway: implication for treatment
C. Migali, A. Bielinska, J. Bhosle, M. O'Brien
20141 citations
Semantic Scholar
18 Evaluation of the Scan and Follow Up (SCAFU) clinic at the Royal Marsden Hospital
C. Milner-Watts, J. Bhosle, A. Minchom, S. Popat +10 more
2026Lung Cancer0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Popat×26
Invite
S. Popat — researcher profile on SciRah
A. Minchom×22
Invite
A. Minchom — researcher profile on SciRah
M. O'Brien×21
Invite
M. O'Brien — researcher profile on SciRah
M. O'Brien×12
Invite
M. O'Brien — researcher profile on SciRah

×11

Invite

T. Yap — researcher profile on SciRah

C. Milner-Watts×10

Invite

C. Milner-Watts — researcher profile on SciRah

Nadia Yousaf×10

Invite

Nadia Yousaf — researcher profile on SciRah

Invite

J. de Bono — researcher profile on SciRah

Invite

R. Gunapala — researcher profile on SciRah

Invite

U. Banerji — researcher profile on SciRah

Invite

I. Locke — researcher profile on SciRah

Invite

S. Popat — researcher profile on SciRah